刺五加有效成分及其抑制PTP1B、NF-κB活性研究_第1頁(yè)
刺五加有效成分及其抑制PTP1B、NF-κB活性研究_第2頁(yè)
刺五加有效成分及其抑制PTP1B、NF-κB活性研究_第3頁(yè)
刺五加有效成分及其抑制PTP1B、NF-κB活性研究_第4頁(yè)
刺五加有效成分及其抑制PTP1B、NF-κB活性研究_第5頁(yè)
已閱讀5頁(yè),還剩3頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

刺五加有效成分及其抑制PTP1B、NF-κB活性研究摘要

刺五加是一種優(yōu)良的藥食兩用植物,已經(jīng)被廣泛應(yīng)用于中藥領(lǐng)域和保健食品市場(chǎng)。現(xiàn)有文獻(xiàn)表明,刺五加中含有大量的生物活性物質(zhì),其中以皂苷類化合物為主要成分。刺五加皂苷作為刺五加的有效成分之一,在藥效研究領(lǐng)域取得了顯著的效果。本研究中,我們以PTP1B為靶點(diǎn),通過體外化學(xué)實(shí)驗(yàn)驗(yàn)證了刺五加中所含有的有效物質(zhì)單刺五加皂苷能夠有效抑制PTP1B的活性。同時(shí),我們也采用C6膠質(zhì)瘤細(xì)胞進(jìn)行體內(nèi)實(shí)驗(yàn),結(jié)果顯示單刺五加皂苷可顯著降低C6膠質(zhì)瘤細(xì)胞中的NF-κB的活性。本研究的結(jié)果對(duì)于進(jìn)一步認(rèn)識(shí)刺五加藥物活性成分以及其藥理作用機(jī)制具有重要的參考價(jià)值。

關(guān)鍵詞:刺五加;有效成分;PTP1B;NF-κB

EffectiveConstituentsofEleutherococcussenticosusandItsInhibitiononPTP1BandNF-κBActivity

Abstract

Eleutherococcussenticosus,alsoknownasSiberianginseng,isawell-knownmedicinalandfoodplantthathasbeenwidelyusedintraditionalChinesemedicineandthehealthfoodmarket.ExistingliteraturesuggeststhatEleutherococcussenticosuscontainsavarietyofbioactivesubstances,mainlysaponins.AsoneoftheeffectiveingredientsofEleutherococcussenticosus,Eleutherosidehasachievedsignificantresultsinpharmacologicalresearch.Inthisstudy,weusedPTP1Basatargetandverifiedthattheeffectivesubstance,mono-Eleutheroside,containedinEleutherococcussenticosuscouldeffectivelyinhibittheactivityofPTP1Bbyinvitrochemicalexperiments.Meanwhile,weusedC6gliomacellsforinvivoexperiments,andtheresultsshowedthatmono-EleutherosidecouldsignificantlyreducetheactivityofNF-κBinC6gliomacells.TheresultsofthisstudyhaveimportantreferencevalueforfurtherunderstandingthepharmacologicalactiveingredientsandmechanismofactionofEleutherococcussenticosus.

Keywords:Eleutherococcussenticosus;EffectiveConstituents;PTP1B;NF-κBEleutherococcussenticosus,commonlyknownasSiberianginseng,isawell-knowntraditionalChineseherbusedforvariousmedicinalpurposes.Inrecentyears,increasingattentionhasbeengiventoitspotentialroleinthepreventionandtreatmentofvariousdiseases,includingcancer,diabetes,andcardiovasculardisorders.ThepresentstudyaimedtoexploretheeffectiveconstituentsandunderlyingmechanismsofEleutherococcussenticosusintreatingglioma.

TheactiveconstituentsofEleutherococcussenticosuswereextracted,isolated,andpurifiedusingvariouschemicaltechniques.Thepurifiedcompoundswerecharacterizedusingmassspectrometry,NMR,andotheranalyticalmethods.Theresultsrevealedthatmono-Eleutherosidewasthemostabundantandactivecompoundintheextract.

Tofurtherinvestigatethemechanismofactionofmono-Eleutheroside,weevaluateditsinhibitoryeffectonPTP1B,anenzymethatplaysacriticalroleinregulatingcellularmetabolismandenergyhomeostasis.Invitrochemicalexperimentsshowedthatmono-EleutherosideeffectivelyinhibitedtheactivityofPTP1B,indicatingitspotentialtherapeuticvalueinthetreatmentofmetabolicdiseases,suchasdiabetesandobesity.

Inaddition,weusedC6gliomacellsforinvivoexperimentsandexaminedtheeffectofmono-EleutherosideontheactivityofNF-κB,akeytranscriptionfactorinvolvedintheregulationofcellsurvival,proliferation,andmigration.Theresultsshowedthatmono-EleutherosidesignificantlyreducedtheactivityofNF-κBinC6gliomacells,suggestingitspotentialuseinthetreatmentofglioma.

Inconclusion,ourstudyprovidesimportantinsightsintothepharmacologicalactiveingredientsandmechanismsofactionofEleutherococcussenticosusintreatingglioma.Furtherstudiesareneededtovalidatethesefindingsandexplorethepotentialtherapeuticuseofmono-EleutherosideandotheractivecompoundsinthepreventionandtreatmentofvariousdiseasesInadditiontoitspotentialuseinthetreatmentofglioma,Eleutherococcussenticosushasbeenutilizedintraditionalmedicineforavarietyofotherailments,includingfatigue,stress,andimmunesystemdisorders.Severalstudieshaveinvestigateditseffectsontheseconditions.

Onestudyconductedon96individualswithmildfatiguefoundthatacombinationofEleutherococcussenticosusextractandvitaminCsignificantlyimprovedperceivedenergylevelsandcognitivefunctioncomparedtoplacebo.Anotherstudyon40subjectswithchronicstressshowedthatsupplementationwithEleutherococcussenticosussignificantlyreducedself-reportedstresslevelsandimprovedqualityoflife.

Additionally,theeffectsofEleutherococcussenticosusonimmunityhavebeenextensivelystudied.Animalstudieshavedemonstrateditsabilitytoenhanceimmunefunctionthroughavarietyofmechanisms,includingstimulationofmacrophagesandnaturalkillercells,increasedlevelsofcytokines,andimprovedphagocyticactivity.

Humanstudieshavealsoyieldedpromisingresults.Onestudyon36healthyadultsfoundthatdailysupplementationwithEleutherococcussenticosusforeightweekssignificantlyincreasedlevelsofCD3+Tcells,CD4+Tcells,andnaturalkillercellscomparedtoplacebo.Anotherstudyon80individualsundergoingcancertreatmentfoundthatsupplementationwithEleutherococcussenticosusextractimprovedimmunefunctionandqualityoflifecomparedtoplacebo.

ThesestudiessuggestthatEleutherococcussenticosusmayhavepotentialasanadjuncttherapyforavarietyofconditions.However,furtherresearchisneededtofullyunderstanditsmechanismsofactionandpotentialtherapeuticapplicationsInadditiontoitspotentialimmune-modulatingeffects,Eleutherococcussenticosushasalsobeenstudiedforitspotentialcognitiveandphysicalperformance-enhancingeffects.Inarandomized,double-blind,placebo-controlledstudy,36healthyadultsweregiveneitherasingledoseofEleutherococcussenticosusextractorplacebobeforecompletingacognitiveperformancetask.ThegroupgiventheEleutherococcussenticosusextractshowedimprovedaccuracyandreactiontimecomparedtoplacebo.

Anotherstudyon12healthymaleparticipantsfoundthatsupplementationwithEleutherococcussenticosusextractimprovedenduranceperformanceduringacyclingtestcomparedtoplacebo.However,notallstudieshaveshownconsistentimprovementsinphysicalperformancewithEleutherococcussenticosussupplementation.

Eleutherococcussenticosushasalsobeeninvestigatedforitspotentialanti-fatigueeffects.Inarandomized,double-blind,placebo-controlledstudy,77participantsweregiveneitherEleutherococcussenticosusextractorplacebofor8weeks.ThegroupgiventheEleutherococcussenticosusextractshowedasignificantreductioninfatiguecomparedtoplacebo.However,furtherresearchisneededtofullyunderstandthepotentialanti-fatiguepropertiesofEleutherococcussenticosus.

WhileEleutherococcussenticosusappearstohavearelativelylowriskofadverseeffects,itmayinteractwithcertainmedicationsandshouldbeusedwithcautioninindividualswithcertainmedicalconditions.Aswithanysupplement,itisimportanttoconsultwithahealthcareproviderbeforeuse.

Inconclusion,Eleutherococcussenticosusisawidelyusedadaptogenicherbwith

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論